Article
Cytochrome P450 3A4FNx011B as pharmacogenomic predictor of tacrolimus pharmacokinetics and clinical outcome in the liver transplant recipients.
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association - 1 Jan 2000
Albekairy Abdulkareem, Alkatheri Abdulmalik, Fujita Shiro, Hemming Alan, Howard Richard, Reed Alan, Karlix Janet
Abstract excerpt
BACKGROUND AND AIMS: Tacrolimus is a macrolide immunosuppressant used for prevention of allograft rejection in organ transplantation and metabolized in the liver and intestine by cytochrome P450 3A4 (CYP3A4) enzyme. A single nucleotide polymorphism (SNP) in the CYP3A4 promoter region has been identified. It has been shown that the presence of CYP3A4FNx011B allele (variant GG) is associated with a reduced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
